Tajikistan Triples the Production of Medicines
Read also
DUSHANBE, 02.10.2023 (NIAT Khovar) – The volume of exports of biologically active herbal supplements from Tajikistan this year increased by 63.25 million somoni compared to last year. This was stated on September 29 during the Dushanbe International Investment Forum — 2023 in the section “Investment opportunities in the healthcare sector, prospects for the development of the pharmaceutical sector and private medicine in Tajikistan.”
The volume of production of medicines and medical products produced in Tajikistan in 2022 compared to the same period the year before increased by 3 times.
The State Program for the Development of the Pharmaceutical Industry in Tajikistan for 2021-2025 is being successfully implemented to develop the pharmaceutical industry in the country.
As part of the program, 58 domestic enterprises began producing 560 types of medicines and medical products.
These enterprises provide new jobs for more than 450 specialists and workers, and up to 4,000 workers are involved in seasonal work.
Tajikistan, EBRD sign loan and grant agreements for energy loss reduction project
Tajikistan to Welcome Global Investors at “Dushanbe Invest-2025” Forum
Tajikistan’s Transport Minister Highlights Importance of Joint Projects in Seoul
Tajik–Swiss Business Forum Held in Dushanbe
Direct Air Connectivity Established Between Xi’an and Dushanbe
Tajik Delegation Participates in 69th IAEA General Conference
Swiss Cooperation Office Ready to Develop New Initiatives in Tajikistan
Tajikistan attracts USD213 million from international financial organizations
Tajikistan Chamber of Commerce and Industry Opens Representative Office in Beijing
International Artificial Intelligence Conference to Be Held in Dushanbe in October
Tajikistan’s Foreign Trade Turnover Exceeds $4.7 Billion in First Half of 2025
Chinese Investors Familiarize Themselves with Activities of Kulob Free Economic Zone
